- Company/Commercial (13)
- Banking / Finance (11)
- Corporate (9)
- Financial services (6)
- Pharma/Biotech (5)
- Energy (4)
- Insolvency & restructuring (4)
- Pensions (4)
- Private Equity (4)
- Employment (3)
- Real Estate (3)
- Tax (3)
- Business Tax (2)
- Environment (2)
- Intellectual Property (2)
- Regulatory and compliance (2)
- Charities (1)
- Commodities (1)
- Competition/EU (1)
- Healthcare (1)
- Immigration (1)
- Personal tax / Trusts (1)
- PPP/PFI/Commercial projects (1)
- Private Client (1)
Sort By: Newest first | Oldest first
In the current market, private equity sponsors are increasingly looking at initial public offerings (IPOs) as a real exit option for their portfolio investments.
Taylor Wessing private equity partner Ed Waldron meets with Rob McCombie, investment director at CBPE Capital.
MAC has published a report on the Tier 1 investor visa, which focuses on whether the investment thresholds of the current scheme provide sufficient economic benefits to the UK.
This article looks at what prompted the Law Commission’s consultation on the fiduciary duties of investment intermediaries, what it is focused on and what might come next.
A term sheet is a document that outlines the key financial and other terms of a proposed investment.
Fundraisings of early-stage life science companies can be complicated affairs from the point of view of actually securing the funds from investors in the first place.
The articles of association are a contract between the company and each shareholder and between the shareholders themselves.
A life sciences company raises funds either by issuing shares or by borrowing money from individuals, venture capital bodies or lending institutions.
A number of life sciences industry bodies have jointly published a report entitled ‘From vision to action: delivery of the strategy for UK life sciences’.
All the existing shareholders and the company should be a party to the agreement, although it may not be practical for all minority shareholders to be a party if there is a large number of them.
It is common in investments for life sciences companies for a term sheet to be put in place between the investors and the founders that sets out the key terms of the investment.
Welcome to Taylor Wessing’s analysis of clean energy investment activity in the fourth quarter of 2013.
The Pension Protection Fund has recently published an explanatory statement entitled ‘Restructuring and insolvency: the PPF approach’.
The Chinese government has taken a big step towards liberalising the Chinese outbound investment regime.
Taylor Wessing asked lawyers across its restructuring and corporate recovery team to describe how things might develop in this market during 2014.
Cross-border investment and M&A between China and Europe in the clean energy sector was quiet in 2013.
Following the release of the Autumn Statement, Taylor Wessing has summarised some of the main announcements.
Legal treatment of matters related to securing debts (in the old terminology, ‘securing obligations’) will be significantly changed by the new Czech Civil Code effective from 1 January 2014.
Welcome to Taylor Wessing’s analysis of clean energy investment activity in the third quarter of 2013 (3Q13).
In publishing CP13/131, the FCA sets out a proposal for the regulation of crowdfunding, covering both peer-to-peer lending and investment-based crowdfunding platforms.